Wells Fargo’s Elanco Animal Health Incorporated 5.00% Tangible Equity Units ELAT Stock Holding History

Wells Fargo’s Portfolio ELAT Stock Details ELAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,125	Closed	-$22K	–	7899
2022 Q4	$22K	Hold	1,125	–	–	﹤0.01%	5218
2022 Q3	$24K	Hold	1,125	–	–	﹤0.01%	5315
2022 Q2	$36K	Hold	1,125	–	–	﹤0.01%	5179
2022 Q1	$46K	Hold	1,125	–	–	﹤0.01%	5703
2021 Q4	$50K	Sell	1,125 -2,875	-72%	-$138K	﹤0.01%	5966
2021 Q3	$199K	Hold	4,000	–	–	﹤0.01%	5095
2021 Q2	$215K	Sell	4,000 -10,350	-72%	-$520K	﹤0.01%	4999
2021 Q1	$658K	Buy	14,350 +6,350	+79%	+$305K	﹤0.01%	4528
2020 Q4	$391K	Sell	8,000 -89,000	-92%	-$4.25M	﹤0.01%	4705
2020 Q3	$4.3M	Buy	+97,000	New	+$4.09M	﹤0.01%	2648
2020 Q2	–	Sell	-2,800	Closed	-$115K	–	7055
2020 Q1	$115K	Buy	+2,800	New	+$134K	﹤0.01%	4992

Wells Fargo's ELAT Position: Q1 2023 in Review

Wells Fargo sold out of Elanco Animal Health Incorporated 5.00% Tangible Equity Units (ELAT) in Q1 2023, closing a stake of 1,125 shares — an estimated $22K sold.

Wells Fargo first reported a position in ELAT in Q1 2020 and held it in 11 quarters. The position peaked at $4.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold ELAT as of Q1 2023.

Wells Fargo reported no remaining Elanco Animal Health Incorporated 5.00% Tangible Equity Units position as of Q1 2023 after selling out during the quarter.
Wells Fargo sold 1,125 Elanco Animal Health Incorporated 5.00% Tangible Equity Units shares in Q1 2023, an estimated $22K.
Wells Fargo first reported a position in Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q1 2020 and held it in 11 quarters.
Wells Fargo's Elanco Animal Health Incorporated 5.00% Tangible Equity Units position peaked at $4.3M in Q3 2020.
0 funds tracked by Wall St. Rank held Elanco Animal Health Incorporated 5.00% Tangible Equity Units as of Q1 2023.

Based on Wells Fargo's 13F filing for Q1 2023, filed 12 May 2023.